Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349152 · ClinicalTrials.gov registry record · Phase 4
Remifentanil and Glycemic Response in Cardiac Surgery
A Phase 4 study, sponsored by Kathirvel Subramaniam.
- Completed
- Registry status
- Phase 4
- Development phase
- 116
- Enrollment target
NCT02349152 is a Phase 4 study that has completed, run by Kathirvel Subramaniam. The registered enrollment target is 116 participants.
The verdict
NCT02349152, a Phase 4 study, has completed, sponsored by Kathirvel Subramaniam.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 116 participants
- Enrollment target
Study Summary
This study evaluates the effect of using remifentanil during cardiopulmonary bypass surgery to supress the hyperglycemic response in perioperative period. Half of the participants will receive continuous intravenous remifentanil during surgery, while the other half will receive intermittent intravenous fentanyl during surgery. Intermittent intravenous fentanyl administration is this institution's standard of care.
Interventions
- DRUG Fentanyl
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02349152
The ClinicalTrials.gov registry entry for NCT02349152 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kathirvel Subramaniam, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fentanyl is the first listed.
NCT02349152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02349152 about?
NCT02349152 is a clinical study titled "Remifentanil and Glycemic Response in Cardiac Surgery". This study evaluates the effect of using remifentanil during cardiopulmonary bypass surgery to supress the hyperglycemic response in perioperative period. Half of the participants will receive continuous intravenous remifentanil during surgery, while the other half will receive intermittent intraven...
What is the current status of trial NCT02349152?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 116 participants. The study started on 2016-01. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02349152?
The interventions under investigation include: Fentanyl (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT02349152?
This trial is sponsored by Kathirvel Subramaniam, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.